Literature DB >> 10559534

Measles elimination: progress and challenges.

F T Cutts1, A Henao-Restrepo, J M Olivé.   

Abstract

The accelerating progress in reducing measles incidence and mortality in many parts of the world has led to calls for its global eradication during the next 10-15 years. Three regions have established goals of elimination of indigenous transmission of measles. The strategy used in the Americas of a mass 'catchup' campaign of children 9 months to 15 years of age, high coverage through routine vaccination of infants, intensive surveillance and follow-up campaigns to prevent excessive build-up of susceptibles has had great success in reducing measles transmission close to zero. However, while these developments are impressive, much remains to be done to reduce measles-associated mortality in western and central Africa, where less than half of children are currently receiving measles vaccine and half a million children die from measles each year. The obstacles to global measles eradication are perceived to be predominantly political and financial. There are also technical questions, however. These include the refinement of measles elimination strategies in the light of recent outbreaks in the Americas; the implications of the HIV epidemic for measles elimination, issues around injection safety, and concerns about the possibility that secondary vaccine failures will contribute in sustaining transmission in highly vaccinated populations. The global priorities are to improve measles control in low income countries, increase awareness among industrialized countries of the importance of measles, and conduct studies to answer the technical questions about measles elimination strategies.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10559534     DOI: 10.1016/s0264-410x(99)00309-6

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  22 in total

Review 1.  Improving child health: the role of research.

Authors:  F Dabis; J Orne-Gliemann; F Perez; V Leroy; M L Newell; A Coutsoudis; H Coovadia
Journal:  BMJ       Date:  2002-06-15

2.  Synthesizing epidemiological and economic optima for control of immunizing infections.

Authors:  Petra Klepac; Ramanan Laxminarayan; Bryan T Grenfell
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-08       Impact factor: 11.205

3.  Toll-like receptor 7 and 8 polymorphisms: associations with functional effects and cellular and antibody responses to measles virus and vaccine.

Authors:  Holly D Clifford; Stephanie T Yerkovich; Siew-Kim Khoo; Guicheng Zhang; John Upham; Peter N Le Souëf; Peter Richmond; Catherine M Hayden
Journal:  Immunogenetics       Date:  2011-09-23       Impact factor: 2.846

4.  Use of cotton rats to evaluate the efficacy of antivirals in treatment of measles virus infections.

Authors:  P R Wyde; D K Moore-Poveda; E De Clercq; J Neyts; A Matsuda; N Minakawa; E Guzman; B E Gilbert
Journal:  Antimicrob Agents Chemother       Date:  2000-05       Impact factor: 5.191

5.  The use of oral fluid samples spotted on filter paper for the detection of measles virus using nested rt-PCR.

Authors:  Sogol Sheikhakbari; Talat Mokhtari-Azad; Vahid Salimi; Zahra Norouzbabaei; Simin Abbasi; Seyed Mohsen Zahraei; Shohreh Shahmahmoodi
Journal:  J Clin Lab Anal       Date:  2012-05       Impact factor: 2.352

6.  Health: a dream from reality to the future.

Authors:  Chunsong Hu; Qinghua Wu
Journal:  Front Med       Date:  2016-04-18       Impact factor: 4.592

7.  Combination of reverse transcriptase PCR analysis and immunoglobulin M detection on filter paper blood samples allows diagnostic and epidemiological studies of measles.

Authors:  R L De Swart; Y Nur; A Abdallah; H Kruining; H S El Mubarak; S A Ibrahim; B Van Den Hoogen; J Groen; A D Osterhaus
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

8.  Development of an artificial-antigen-presenting-cell-based assay for the detection of low-frequency virus-specific CD8(+) T cells in whole blood, with application for measles virus.

Authors:  Zaza M Ndhlovu; Monika Angenendt; Diana Heckel; Jonathan P Schneck; Diane E Griffin; Mathias Oelke
Journal:  Clin Vaccine Immunol       Date:  2009-06-03

9.  HIV-1 infection in Zambian children impairs the development and avidity maturation of measles virus-specific immunoglobulin G after vaccination and infection.

Authors:  Nitya Nair; William J Moss; Susana Scott; Nanthalile Mugala; Zaza M Ndhlovu; Kareem Lilo; Judith J Ryon; Mwaka Monze; Thomas C Quinn; Simon Cousens; Felicity Cutts; Diane E Griffin
Journal:  J Infect Dis       Date:  2009-10-01       Impact factor: 5.226

Review 10.  Measles, mumps, rubella vaccine (Priorix; GSK-MMR): a review of its use in the prevention of measles, mumps and rubella.

Authors:  Keri Wellington; Karen L Goa
Journal:  Drugs       Date:  2003       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.